DE69628160D1 - Herstellung von natrium chlorid aerosol formulierungen - Google Patents

Herstellung von natrium chlorid aerosol formulierungen

Info

Publication number
DE69628160D1
DE69628160D1 DE69628160T DE69628160T DE69628160D1 DE 69628160 D1 DE69628160 D1 DE 69628160D1 DE 69628160 T DE69628160 T DE 69628160T DE 69628160 T DE69628160 T DE 69628160T DE 69628160 D1 DE69628160 D1 DE 69628160D1
Authority
DE
Germany
Prior art keywords
sodium chloride
preparation
formulations
subject
aerosol formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69628160T
Other languages
English (en)
Inventor
R Clark
C Hsu
J Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69628160D1 publication Critical patent/DE69628160D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69628160T 1995-04-05 1996-03-13 Herstellung von natrium chlorid aerosol formulierungen Expired - Lifetime DE69628160D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/416,998 US5747002A (en) 1995-04-05 1995-04-05 Preparation of sodium chloride aerosol formulations
PCT/US1996/003528 WO1996031221A1 (en) 1995-04-05 1996-03-13 Preparation of sodium chloride aerosol formulations

Publications (1)

Publication Number Publication Date
DE69628160D1 true DE69628160D1 (de) 2003-06-18

Family

ID=23652179

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628160T Expired - Lifetime DE69628160D1 (de) 1995-04-05 1996-03-13 Herstellung von natrium chlorid aerosol formulierungen

Country Status (9)

Country Link
US (1) US5747002A (de)
EP (1) EP0819006B1 (de)
JP (1) JP3427121B2 (de)
AT (1) ATE240111T1 (de)
AU (1) AU717839B2 (de)
CA (1) CA2217047C (de)
DE (1) DE69628160D1 (de)
NZ (1) NZ305168A (de)
WO (1) WO1996031221A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5881720A (en) * 1997-04-29 1999-03-16 The Procter & Gamble Company Method of delivering halotherapy
IE970801A1 (en) * 1997-11-11 1999-05-19 Helsinn Chemicals Ireland Ltd An apparatus for producing a pharmaceutical product
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
AU2001241636A1 (en) * 2000-02-23 2001-09-03 The Procter And Gamble Company Halotherapy method
GB0014898D0 (en) * 2000-06-19 2000-08-09 Innovata Biomed Ltd Delivery system
US6607151B2 (en) * 2001-08-16 2003-08-19 Morris Samelson Ultra fine dead sea mineral compound and method of manufacture
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
AU2004277419B2 (en) * 2003-09-30 2007-10-11 Brown University Research Foundation Nanoparticulate therapeutic biologically active agents
EE00431U1 (et) * 2003-12-09 2004-04-15 Budarin Vladimir Meetod etteantud kontsentratsiooniga soolaaerosooli saamiseks
US20070286804A1 (en) * 2006-06-09 2007-12-13 Allied Research International Inc. Method, materials and apparatus for investigating asthma using dust mite allergen
RO122397B1 (ro) * 2006-11-14 2009-05-29 Constantin Pascu Procedeu şi dispozitiv pentru obţinerea controlată a aerosolilor salini uscaţi
LT5600B (lt) 2007-01-30 2009-10-26 Vladimir Budarin Reguliuojamos koncentracijos druskų aerozolio gavimo būdas ir įrenginys bei individualios haloterapijos įranga
ES2638977T3 (es) 2007-12-04 2017-10-24 Biogen Chesapeake Llc Formulaciones y procedimientos mejorados para liofilización y liofilizados obtenidos por los mismos
WO2009074662A2 (en) * 2007-12-13 2009-06-18 Novartis Ag Organic compounds
CN102497853B (zh) 2009-03-26 2018-03-23 普马特里克斯营业公司 治疗肺病的干粉配方与方法
MD4039C1 (ro) * 2009-11-05 2010-12-31 Институт Химии Академии Наук Молдовы Microsalină artificială de suprafaţă
MD4089C1 (ro) * 2009-11-18 2011-08-31 Институт Химии Академии Наук Молдовы Halocameră artificială de suprafaţă
MD4040C1 (ro) * 2009-12-09 2010-12-31 Институт Химии Академии Наук Молдовы Halocameră artificială de suprafaţă
EP2611438B1 (de) 2010-08-30 2020-04-01 Pulmatrix Operating Company, Inc. Trockenpulverformulierungen und verfahren zur behandlung von lungenerkrankugen
DK2621488T3 (en) 2010-09-29 2019-03-04 Pulmatrix Operating Co Inc CATIONIC DRY POWDER
RU2017144619A (ru) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
FI122446B (fi) * 2010-11-24 2012-01-31 Kari Viherlahti Menetelmä suolapölyn tuottamiseksi ja suolapölygeneraattori
CN109999013A (zh) 2012-02-29 2019-07-12 普马特里克斯营业公司 可吸入干粉剂
DE102012111431A1 (de) 2012-11-26 2014-05-28 Klafs Gmbh & Co. Kg Mikronisator
WO2014165303A1 (en) 2013-04-01 2014-10-09 Pulmatrix, Inc. Tiotropium dry powders
US10219961B2 (en) 2014-06-20 2019-03-05 Hill Top Research Inc. Mobile chamber apparatuses and related methods
DE102016106358B3 (de) 2016-04-07 2017-09-28 Klafs Gmbh & Co. Kg Mikronisator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533065A (en) * 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
GB9408053D0 (en) * 1994-04-22 1994-06-15 Nat Heart & Lung Inst Pharmaceutical preparation

Also Published As

Publication number Publication date
CA2217047A1 (en) 1996-10-10
CA2217047C (en) 2002-11-05
JPH10510292A (ja) 1998-10-06
ATE240111T1 (de) 2003-05-15
EP0819006A1 (de) 1998-01-21
EP0819006B1 (de) 2003-05-14
WO1996031221A1 (en) 1996-10-10
AU717839B2 (en) 2000-04-06
US5747002A (en) 1998-05-05
NZ305168A (en) 1999-08-30
JP3427121B2 (ja) 2003-07-14
AU5311596A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69628160D1 (de) Herstellung von natrium chlorid aerosol formulierungen
MY124282A (en) Methods and compositions for pulmonary delivery of insulin
EP0866726A4 (de)
ZA954101B (en) Medicaments
MX9602246A (es) Uso de furoato de mometasona para crear pasaje de aire y para enfermedades del pulmon.
DE69810355T2 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
EE04628B1 (et) Perforeeritud mikrostruktuure sisaldav pulber ja meetod perforeeritud mikrostruktuure sisaldava mikroosakeste kompositsiooni ning pulbri valmistamiseks
CA2184582A1 (en) Pharmaceutically acceptable dnase formulation
MY108748A (en) Medicaments
GR3035050T3 (en) Method of preparing a viral vector by homologous intermolecular recombination
CA2189882A1 (en) Papillomavirus vaccines
GEP20012345B (en) Dispersible Macromolecule Compositions and Methods for Their Preparation and Use
HUP0101608A2 (hu) Aeroszol formájú gyógyszerkészítmény és eljárás előállítására
PL325339A1 (en) Derivatives of piperasine as neurokinin antagonists
CA2206657A1 (en) Therapeutic preparation for inhalation containing parathyroid hormone, pth
CA2223579A1 (en) Novel recombinant temperature sensitive mutants of influenza
DE69128898D1 (de) Selbstständig zusammenfügende replikationsdefekte hybride viruspartikel
DE69908650D1 (de) Mahlverfahren zur herstellung feingemahlener medizinischer substanzen
DE69806582D1 (de) Verfahren zur herstellung eines therapeutischen puders durch copräzipitation von insulin und einem absorptionsverstärker
AU2596195A (en) Substituted alkyldiamine derivatives and their use as tachykinin antagonists
JPS56164120A (en) Antitumor agent
HUP9902788A1 (hu) Porlasztható makromolekuláris gyógyszerkészítmények, valamint előállításuk és alkalmazásuk
AU9132091A (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
GB2282972A (en) Air filter capsule for nostrils
SE9302198D0 (sv) Powder preparation for inhalation

Legal Events

Date Code Title Description
8332 No legal effect for de